MetLife (MET)
(Delayed Data from NYSE)
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Zacks News
MetLife Suffers From Declining Revenues, Spinoff Charges
by Zacks Equity Research
MetLife's (MET) declining revenues, low premiums, fees and other revenues continue to bother.
Top Stock Reports for CVS Health, Marriott & Enbridge
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including CVS Health (CVS), Marriott (MAR), and Enbridge (ENB).
Are Options Traders Betting on a Big Move in MetLife (MET) Stock?
by Zacks Equity Research
Investors in MetLife (MET) need to pay close attention to the stock based on moves in the options market lately.
AIG Q2 Earnings Beat as Restructuring Initiatives Pay Off
by Zacks Equity Research
American International Group Inc.'s (AIG) second-quarter results benefit from favorable performance by its consumer business, cost control efforts and share buyback.
MetLife (MET) Earnings Beat Estimates in Q2, Improve Y/Y
by Zacks Equity Research
MetLife's (MET) solid Q2 results were driven by the strong performance of all the segments.
MetLife (MET) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Metlife's (MET) second-quarter earnings may gain from higher sales in group benefit and efficient capital management. Derivative losses and foreign exchange volatility may hurt.
Fortress (FIG) to Divest Logan Circle Partners, Stock Down
by Zacks Equity Research
Fortress Investment Group LLC (FIG) entered into an agreement to divest its 100% stake in Logan Circle Partners to MetLife, Inc. (MET).
MetLife to Buy Logan Circle, Expand Investment Management
by Zacks Equity Research
MetLife, Inc. (MET) has entered into a definitive agreement with Fortress Investment to acquire its fixed income asset management business.
MetLife's (MET) Board Okays Brighthouse Spin-Off, Stock Up
by Zacks Equity Research
MetLife, Inc.'s (MET) board of directors has given a green signal to the spin-off of its U.S. life insurance unit named Brighthouse Financial Inc.
Will Changes in Top Brass Boost MetLife's (MET) Growth?
by Zacks Equity Research
MetLife (MET) announced a host of management changes to its top leadership team, which will be effective Jul 1.
Why Is MetLife (MET) Down 1.9% Since the Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Highwoods to Develop MetLife's Office Building in Weston
by Zacks Equity Research
Highwoods Properties, Inc. (HIW) announced that it has been selected by MetLife, Inc. (MET) to develop a third office building for its global technology campus in Cary's mixed-use Weston planned unit development.
The Zacks Analyst Blog Highlights: Gilead, Dow Chemical, MetLife, Tesla and Emerson Electric
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Gilead, Dow Chemical, MetLife, Tesla and Emerson Electric
MetLife (MET) Q1 Earnings & Revenues Top Estimates, Grow Y/Y
by Zacks Equity Research
MetLife, Inc.'s (MET) earnings of $1.46 per share beat the Zacks Consensus Estimate by 14.96% and were up 12.3% year over year.
AIG (AIG) Beats on Q1 Earnings, Growth Initiatives On Track
by Zacks Equity Research
American International Group Inc. (AIG) eanings of $1.36 per share surpassed the Zacks Consensus Estimate by a good 22.5%.
Insurance Stocks Q1 Earnings on May 3: AIG, MET, LNC, PRU
by Zacks Equity Research
The Q1 earnings season is in full swing with 57.6% members of the elite S&P 500 Index reporting solid quarterly numbers so far.
What's in Store for MetLife (MET) this Earnings Season?
by Zacks Equity Research
MetLife Inc. (MET) is scheduled to report first-quarter 2017 results on May 3, after market close.
What's in Store for The Hartford (HIG) this Earnings Season?
by Zacks Equity Research
The Hartford Financial Services Group, Inc. (HIG) will release first-quarter 2017 financial results on Apr 27, after the closing bell.
Profit from These 5 Sturdy Stocks as Fear Grips Markets
by Tirthankar Chakraborty
Wall Street's fear gauge is breaking out higher as geopolitical risks heat up after the U.S. opted for 'Mother of All Bombs'.
Why Is MetLife (MET) Up 3.8% Since the Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Allstate (ALL) Takes Initiatives for Growth, Risks Remain
by Zacks Equity Research
Allstate Corporation (ALL), one of the nation's largest personal lines insurer serving more than 16 million households.
Insurance ETFs Leading Financial Sector in Q4 Earnings
by Sweta Killa
Earnings from the insurance industry have particularly been strong with most players beating both our earnings and revenue estimates.
Metlife Lower on Q4 Earnings Miss, Reports $2.1 Billion Net Loss
by Parth Panchal
Metlife, Inc. (MET) just released its fourth quarter fiscal 2016 earnings results, posting earnings of $1.28 per share and revenue of $17.2 billion.
Options Traders Expect Huge Moves in MetLife (MET) Stock
by Zacks Equity Research
MetLife (MET) warrants investors' attention based on moves in the options market lately.
What's in Store for Metlife (MET) this Earnings Season?
by Zacks Equity Research
MetLife, Inc. (MET) is scheduled to report fourth-quarter and full-year 2016 results on Feb 1, after market close.